Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
<p>Glioblastoma (GBM) remains a cancer of high unmet clinical need. Current standard of care for GBM, consisting of maximal surgical resection, followed by ionisation radiation (IR) plus concomitant and adjuvant temozolomide (TMZ), provides less than 15-month survival benefit. Efforts by conve...
Main Authors: | Johanssen, T, McVeigh, L, Erridge, S, Higgins, G, Straehla, J, Frame, M, Aittokallio, T, Carragher, NO, Ebner, D |
---|---|
Format: | Journal article |
Published: |
Frontiers Media
2023
|
Similar Items
-
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
by: Timothy Johanssen, et al.
Published: (2023-01-01) -
A chemogenomic HTS for combinatorial drug discovery in glioblastoma
by: Johanssen, T, et al.
Published: (2022) -
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells
by: Paschalis Athanasiadis, et al.
Published: (2023-07-01) -
Where are all the surgeons in clinical academia?
by: McVeigh, J, et al.
Published: (2022) -
The violinist in London's concert life, 1750-1784 : Felice Giardini and his contemporaries
by: McVeigh, S
Published: (1979)